Personalis Ownership | Who Owns Personalis?

Overview Forecast RevenueFinancials Chart Transcripts

Personalis Ownership Summary

Personalis is owned by 68.28% institutional investors, 31.36% insiders, and 0.37% retail investors. Merck is the largest institutional shareholder, holding 15.87% of PSNL shares. ARK Genomic Revolution ETF is the top mutual fund, with 9.10% of its assets in Personalis shares.

PSNL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Personalis	68.28%	31.36%	0.37%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Diagnostics & Research Stocks	57.29%	10.84%	31.88%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Merck	14.04M	15.87%	$92.13M
Ark investment management	7.11M	8.03%	$46.63M
Blackrock	3.29M	6.50%	$3.85M
Blackrock funding, inc. /de	5.20M	5.88%	$34.14M
Aigh capital management	3.72M	4.21%	$24.43M
Vanguard group	1.73M	2.84%	$10.03M
Millennium management	1.32M	2.16%	$7.61M
Abrdn	1.76M	1.99%	$11.54M
Blue water life science advisors, lp	1.68M	1.89%	$11.00M
Renaissance	920.87K	1.51%	$5.32M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Merck	14.04M	42.73%	$92.13M
Aigh capital management	3.72M	10.99%	$24.43M
Blue water life science advisors, lp	1.68M	8.70%	$11.00M
Perkins capital management	252.50K	1.67%	$1.66M
Wellington shields	292.49K	0.54%	$1.92M
Bruce	253.00K	0.54%	$1.66M
Wellington shields capital management	426.33K	0.47%	$2.80M
Ark investment management	7.11M	0.34%	$46.63M
Green alpha advisors	28.39K	0.18%	$185.11K
Kennedy capital management	653.38K	0.10%	$4.29M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	5.20M	0.00%	2.21M
T. rowe price investment management	1.26M	0.01%	1.26M
Susquehanna group, llp	873.10K	0.00%	718.34K
Blue water life science advisors, lp	1.68M	8.70%	500.90K
Exoduspoint capital management, lp	437.37K	0.03%	403.20K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	1.32M	0.00%	-1.12M
Marshall wace, llp	-	-	-696.29K
Qube research	19.24K	0.00%	-383.04K
Acadian asset management	39.16K	0.00%	-271.36K
Jane street group	-	-	-247.01K

New Positions

Holder	Shares	% Assets	Change	Value
T. rowe price investment management	1.26M	0.01%	1.26M	$8.29M
Polar asset management partners	71.70K	0.01%	71.70K	$470.35K
Mach-1 financial group	48.82K	0.09%	48.82K	$320.27K
Intech investment management	26.32K	0.00%	26.32K	$172.64K
Mariner	16.39K	0.00%	16.39K	$107.49K

Sold Out

Holder	Change
Org partners	-100.00
Redwood wealth management group	-100.00
Nelson, van denburg & campbell wealth management group	-100.00
Creative planning	-157.00
Signaturefd	-158.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	107	0.94%	60,437,524	85.26%	68	4.91%	69	13.11%	25	-10.71%
Mar 31, 2025	108	-0.92%	54,828,815	6.28%	62	0.88%	62	12.73%	28	-20.00%
Dec 31, 2024	59	-32.18%	23,614,794	-19.46%	38	1.68%	25	-37.50%	22	-24.14%
Sep 30, 2024	87	24.29%	29,319,370	33.53%	48	2.56%	40	110.53%	29	-
Jun 30, 2024	70	-4.11%	21,956,674	-1.41%	43	2.03%	19	-44.12%	29	20.83%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Genomic Revolution ETF	8.07M	9.10%	-28.79K
ARK Genomic Revolution	6.95M	7.84%	-118.85K
Vanguard Total Stock Mkt Idx Inv	1.74M	1.97%	-38.65K
Nikko Gbl All Biological Genome Eq MF	932.69K	1.41%	-150.91K
iShares Russell 2000 ETF	1.24M	1.40%	-
Vanguard US Total Market Shares ETF	1.21M	1.37%	-
abrdn Healthcare Investors	1.18M	1.33%	203.94K
abrdn Life Sciences Investors	1.01M	1.14%	94.84K
T. Rowe Price Small-Cap Value	764.05K	0.86%	-1.75K
T. Rowe Price Small-Cap Stock	729.61K	0.82%	729.61K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 28, 2025	Chen Richard	CHIEF MEDICAL OFFICER AND EVP	Sell	$2.97K
Jul 28, 2025	Tachibana Aaron	CFO AND COO	Sell	$4.21K
May 16, 2025	Tachibana Aaron	CFO AND COO	Sell	$6.39K
May 16, 2025	Moore Stephen Michael	SVP and Chief Legal Officer	Sell	$8.29K
May 16, 2025	Chen Richard	CHIEF MEDICAL OFFICER AND EVP	Sell	$4.50K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	2
2025 Q2	-	3
2025 Q1	-	2
2024 Q4	-	7
2024 Q3	1	2

PSNL Ownership FAQ

Who Owns Personalis?

Personalis shareholders are primarily institutional investors at 68.28%, followed by 31.36% insiders and 0.36% retail investors. The average institutional ownership in Personalis's industry, Diagnostics & Research Stocks, is 57.29%, which Personalis exceeds.

Who owns the most shares of Personalis?

Personalis’s largest shareholders are Merck (14.04M shares, 15.87%), Ark investment management (7.11M shares, 8.03%), and Blackrock (3.29M shares, 6.50%). Together, they hold 30.39% of Personalis’s total shares outstanding.

Does Blackrock own Personalis?

Yes, BlackRock owns 6.50% of Personalis, totaling 3.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.85M$. In the last quarter, BlackRock increased its holdings by 11.39K shares, a 0.35% change.

Who is Personalis’s biggest shareholder by percentage of total assets invested?

Merck is Personalis’s biggest shareholder by percentage of total assets invested, with 42.73% of its assets in 14.04M Personalis shares, valued at 92.13M$.

Who is the top mutual fund holder of Personalis shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Personalis shares, with 9.10% of its total shares outstanding invested in 8.07M Personalis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools